ASP Isotopes Inc. Common Stock (ASPI) Revenue Quarterly: History & Chart

ASP Isotopes Inc. Common Stock(ASPI)

Chemicals - Specialty · Dallas, TX

$2.81-0.12 (-4.09%)

Delayed quote: Oct 6, 2026, 12:10 PM EDT

About ASP Isotopes Inc. Common Stock

ASP Isotopes Inc. is an emerging advanced materials company, currently in its pre-commercial stage. This firm is dedicated to the comprehensive management of isotopes, encompassing their creation, dissemination, promotion, and eventual sale. The company's developmental portfolio includes Molybdenum-100, a non-radioactive isotope designed for medical applications, alongside Carbon-14 and Silicon-28. Furthermore, ASP Isotopes is involved with Uranium-235, a specific uranium isotope considered crucial for the carbon-free energy sector. Established in 2021, the company maintains its headquarters in Boca Raton, Florida.

Dallas, TX

271 employees

aspisotopes.com

Basic Materials / Chemicals - Specialty

Sector: Basic Materials
Industry: Chemicals - Specialty
CEO: Paul Elliot Mann

View full financials

Quarterly Revenue

Basis: latest reported fiscal quarter (Q2 FY2026). Source: stored company filings; unavailable inputs remain N/A.

The latest quarterly revenue is $5.12M with QoQ Growth of +22.56%. Quarterly revenue is the total sales generated during the latest fiscal quarter.

Revenue TTM|Revenue Annual|Revenue CAGR|Financials

Quarterly Revenue

ASPI Quarterly Revenue

$5.12M

Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $5.12M.

ASPI P/S Ratio

Full P/S Ratio page

P/S Ratio

ASPI P/S Ratio Chart

11.47

FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T16:10:48.847Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.

ASPI EV/Sales

Full EV/Sales page

EV/Sales

ASPI EV/Sales Chart

13.09x

Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T16:10:48.847Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.

Quarterly Revenue History

Period	Quarterly Revenue	QoQ Growth	YoY Growth
Q2 FY2026Period end 2026-06-30	$5.12M	+22.56%	+327.51%
Q1 FY2026Period end 2026-03-31	$4.18M	(74.91%)	+279.45%
Q4 FY2025Period end 2025-12-31	$16.66M	+240.72%	+1295.41%
Q3 FY2025Period end 2025-09-30	$4.89M	+308.02%	+349.53%
Q2 FY2025Period end 2025-06-30	$1.20M	+8.78%	+17.22%
Q1 FY2025Period end 2025-03-31	$1.10M	(7.73%)	+31.09%
Q4 FY2024Period end 2024-12-31	$1.19M	+9.76%	+175.71%
Q3 FY2024Period end 2024-09-30	$1.09M	+6.40%	N/A
Q2 FY2024Period end 2024-06-30	$1.02M	+21.65%	N/A
Q1 FY2024Period end 2024-03-31	$840,354	+94.07%	N/A
Q4 FY2023Period end 2023-12-31	$433,026	N/A	N/A
Q3 FY2023Period end 2023-09-30	$0	N/A	N/A
Q2 FY2023Period end 2023-06-30	$0	N/A	N/A
Q1 FY2023Period end 2023-03-31	$0	N/A	N/A
Q4 FY2022Period end 2022-12-31	$0	N/A	N/A
Q3 FY2022Period end 2022-09-30	$0	N/A	N/A
Q2 FY2022Period end 2022-06-30	$0	N/A	N/A
Q1 FY2022Period end 2022-03-31	$0	N/A	N/A
Q4 FY2021Period end 2021-12-31	$0	N/A	N/A
Q3 FY2021Period end 2021-09-30	$0	N/A	N/A

Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.